News

Articles

Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with The Biovac Institute Ltd to manufacture the Pfizer-BioNTech COVID-19 vaccine for distribution within the African Union.

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

Eli Lilly and Company has announced its acquisition of biotech firm Protomer Technologies, giving it a protein-engineering platform for next-generation protein therapeutics.

Lilly Acquires Protomer Technologies in Potential $1-Billion Deal

USP adds services to support supply chain for safe medicines. 

USP Acquires Pharmatech Associates

Reports of myocarditis and pericarditis following Pfizer-BioNTech and Moderna vaccinations prompts warnings.

FDA Adds Warning to mRNA Vaccine Fact Sheets

GlaxoSmithKline will focus on vaccines and specialty medicines while spinning off consumer healthcare business.

GSK Announces Consumer Business Demerger

The US government will invest $3 billion from the American Rescue Plan into a COVID-19 antiviral development strategy.

Biden Administration Invests in Antiviral Medicines

Novavax’s COVID-19 vaccine is 90.4% effective and maintains efficacy when administered with an influenza vaccine.

Novavax Reports on Two Vaccine Efficacy Studies

FDA has granted accelerated approval to Biogen for Aduhelm (aducanumab), a new mAb treatment for Alzheimer’ disease.

FDA Grants Accelerated Approval for Biogen’s Alzheimer’s Drug

The acquisition of Advanz Pharma by Nordic Capital has now completed, in a deal worth $846 million.

Nordic Capital Acquires Advanz Pharma for $846 Million

MilliporeSigma has launched SAFC, a high-purity synthetic cholesterol product, nine months ahead of schedule to meet the lipid demands for COVID-19 messenger RNA therapeutics.

Top News